Ms Diana Li > Fangda Partners > Shanghai, China > Lawyer Profile

Fangda Partners offers an extensive life sciences and healthcare focussed team representing an array of medical technology companies and investors, both PRC and multinational. The team is particularly recommended for its expertise in financing and fundraisings. Practice head Josh Shin is expert on regulatory-related issues including R&D, clinical trials, HGRAC regulation and patient centric transformation. Kate Yin is recommended for handling investigations work in the healthcare space, covering anti-bribery, accounting fraud, securities law, conflict of interest, trade secrets and data security. IP expert Fang Qi, antitrust investigations specialist Michael Han and the M&A and foreign investment focussed Diana Li are also central to the team. Henry He, who joined the firm from C-Stone Pharmaceuticals in January 2023, is a further key name.